Literature DB >> 17126809

A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancer.

Mikael Herlevsen1, Gary Oxford, Celeste Ptak, Jeffrey Shabanowitz, Donald F Hunt, Mark Conaway, Dan Theodorescu.   

Abstract

Phosphatase and tensin homolog (PTEN), deleted on chromosome 10, is a potent tumor suppressor. PTEN expression is reduced in advanced bladder cancer and reduction correlates with disease stage. To gain insights into the function of PTEN in human bladder cancer by identifying its binding partners, we developed a novel IPTG inducible PTEN expression system and evaluated this system in the PTEN null UMUC-3 human bladder cancer xenograft model. In this model, induction of PTEN in vivo resulted in reduced tumor growth. We used mass spectrometry to identify PTEN interaction partners in these cells, which identified known interaction partners major vault protein (MVP) and paxillin as well as a novel interaction partner, TRK fused gene (TFG). In conclusion, using a biologically relevant model system to dissect PTEN tumor suppressor function in human bladder cancer, we identified three molecules important for many cellular functions in complex with PTEN.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126809      PMCID: PMC1933505          DOI: 10.1016/j.bbrc.2006.11.067

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  Paxillin and focal adhesion signalling.

Authors:  C E Turner
Journal:  Nat Cell Biol       Date:  2000-12       Impact factor: 28.824

2.  The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation.

Authors:  J Torres; R Pulido
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

3.  Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.

Authors:  M Tamura; J Gu; K Matsumoto; S Aota; R Parsons; K M Yamada
Journal:  Science       Date:  1998-06-05       Impact factor: 47.728

4.  The lac operator-repressor system is functional in the mouse.

Authors:  C A Cronin; W Gluba; H Scrable
Journal:  Genes Dev       Date:  2001-06-15       Impact factor: 11.361

Review 5.  Phosphoinositide 3-kinase: a key biochemical signal for cell migration in response to chemokines.

Authors:  Y Sotsios; S G Ward
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

6.  PTEN regulates tumor cell adhesion of colon carcinoma cells under dynamic conditions of fluid flow.

Authors:  Jörg Haier; Garth L Nicolson
Journal:  Oncogene       Date:  2002-02-21       Impact factor: 9.867

7.  The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region.

Authors:  M M Georgescu; K H Kirsch; T Akagi; T Shishido; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

Review 8.  Vaults: a ribonucleoprotein particle involved in drug resistance?

Authors:  Marieke H Mossink; Arend van Zon; Rik J Scheper; Pieter Sonneveld; Erik A C Wiemer
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

9.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

10.  The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase.

Authors:  V A Kickhoefer; A C Siva; N L Kedersha; E M Inman; C Ruland; M Streuli; L H Rome
Journal:  J Cell Biol       Date:  1999-09-06       Impact factor: 10.539

View more
  9 in total

1.  Phosphatase and Tensin Homolog (PTEN) Represses Colon Cancer Progression through Inhibiting Paxillin Transcription via PI3K/AKT/NF-κB Pathway.

Authors:  Ling-Li Zhang; Gang-Gang Mu; Qian-Shan Ding; Yan-Xia Li; Yun-bo Shi; Jin-Fen Dai; Hong-Gang Yu
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

Review 2.  PTEN function: the long and the short of it.

Authors:  Benjamin D Hopkins; Cindy Hodakoski; Douglas Barrows; Sarah M Mense; Ramon E Parsons
Journal:  Trends Biochem Sci       Date:  2014-03-18       Impact factor: 13.807

3.  Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer.

Authors:  Rou Wang; David S Morris; Scott A Tomlins; Robert J Lonigro; Alexander Tsodikov; Rohit Mehra; Thomas J Giordano; L Priya Kunju; Cheryl T Lee; Alon Z Weizer; Arul M Chinnaiyan
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

Review 4.  NHERFs, NEP, MAGUKs, and more: interactions that regulate PTEN.

Authors:  Challice L Bonifant; Jung-Sik Kim; Todd Waldman
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

5.  ced-4 and proto-oncogene tfg-1 antagonistically regulate cell size and apoptosis in C. elegans.

Authors:  Ling Chen; Tom McCloskey; Pradeep M Joshi; Joel H Rothman
Journal:  Curr Biol       Date:  2008-07-22       Impact factor: 10.834

6.  TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals.

Authors:  Andrew Chase; Thomas Ernst; Andreas Fiebig; Andrew Collins; Francis Grand; Philipp Erben; Andreas Reiter; Stefan Schreiber; Nicholas C P Cross
Journal:  Haematologica       Date:  2009-10-01       Impact factor: 9.941

7.  Effects of indomethacin on expression of PTEN tumour suppressor in human cancers.

Authors:  Imran Haruna Abdulkareem; Maria Blair
Journal:  Niger Med J       Date:  2013-03

8.  Phosphatase and tensin homologue deleted on chromosome 10.

Authors:  Imran Haruna Abdulkareem; Maria Blair
Journal:  Niger Med J       Date:  2013-03

9.  Transcriptome-(phospho)proteome characterization of brain of a germline model of cytoplasmic-predominant Pten expression with autism-like phenotypes.

Authors:  Stetson Thacker; Charis Eng
Journal:  NPJ Genom Med       Date:  2021-06-02       Impact factor: 8.617

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.